ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2013 American Transplant Congress

    Cardiovascular Risk Profile in Children after Renal Transplantation – Introducing the 4C-T Sub-Study

    A. Melk, D. Kracht, A. Doyon, R. Zeller, M. Litwin, A. Duzowa, B. Sözeri, A. Bayzit, S. Caliskan, E. Wuehl, F. Schaefer, B. Schmidt

    Hannover Medical School, Hannover, Germany; University of Heidelberg, Heidelberg, Germany

    Children with chronic kidney disease (CKD) carry an increased cardiovascular risk up to 1000-fold that of the age-matched general population. The 4C-T (Cardiovascular Comorbidity in…
  • 2013 American Transplant Congress

    Epitope Analysis of col(V)-Specific Th17 Cell Responses in Lung Transplantation Reveals an HLA-DRB1*1501 Bias in Both Patient and Donor

    W. Burlingham, M. Keller, L. Haynes, E. Gan, V. Agashe, G. Leverson

    Surgery, UW Madison, Madison, WI

    Fibro-obliterative disease of the airways and vessels is a key element of the chronic rejection process after heart and lung transplantation. Th17 cellular immune responses…
  • 2013 American Transplant Congress

    Assessment of CMV Antiviral Resistance Mutations in Clinical Samples

    S. Kleiboeker, B. Schindel, M. Altrich, J. Hester, J. Dannehl, I. Caton, J. Nutt

    Viracor-IBT Laboratories, Lee's Summit, MO

    Cytomegalovirus (CMV) infections are a major cause of disease among immunocompromised patients. In this population, prolonged antiviral therapy is often necessary to prevent or treat…
  • 2013 American Transplant Congress

    Harmonization of an LC-MS/MS Assay for Therapeutic Drug Monitoring of Tacrolimus

    C. Joynes, D. Mason, T. Annesley, E. Champarnaud, C. Mussell, L. Calton, L. Harter, D. McKeown

    Waters Corp., Milford, MA; The University of Michigan, Ann Arbor, MI; LGC Limited, Teddington, United Kingdom; Waters Corp., Manchester, United Kingdom; Analytical Services International Ltd., London, United Kingdom

    Background: Monitoring concentrations of tacrolimus in allograft recipients is considered the standard of care. Trough concentrations are regarded as a good surrogate for tacrolimus exposure.…
  • 2013 American Transplant Congress

    Targeting of mTORC2 in DC Elicits an Enhanced Pro-Inflammatory Profile and Th17 Alloresponse

    D. Raich-Regue, B. Rosborough, K. Lee, M. Boothby, H. Turnquist, A. Thomson

    Department of Surgery and Department of Immunology, Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA; Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN

    Mammalian target of rapamycin (mTOR) is an important, yet poorly understood integrative kinase that regulates immune cell function. mTOR functions in two independent complexes,- mTOR…
  • 2013 American Transplant Congress

    Pronounced Impact of Community Risk Factors on Pre-Transplant Kidney Candidate Processes and Outcomes

    E. Heaphy, L. Buccini, T. Srinivas, E. Poggio, D. Goldfarb, S. Flechner, J. Rodrigue, D. Thornton, A. Sehgal, J. Schold

    Cleveland Clinic, Cleveland; Medical University of South Carolina, Charelston; Beth Israel Deaconess Medical Center, Boston; Case Western Reserve University, Cleveland

    IntroductionThere are many potential factors which are associated with patient outcomes beyond traditional clinical and donor characteristics.MethodsWe merged national SRTR data with data aggregated from…
  • 2013 American Transplant Congress

    Fish Oil Diet Overcomes Genetic Predisposition Restoring Hepatocyte Proliferation in Livers of A20 Heterozygous Mice Following Partial Hepatectomy

    C. Da Silva, P. Studer, E. Csizmadia, D. Minussi, K. Daniels, C. Ferran

    Surgery, Beth Israel Deaconess Medical Center - HMS, Boston, MA

    Increased free fatty acids (FA) metabolism following partial hepatectomy (PH) is required to meet energy demands of liver regeneration (LR). Impact of dietary lipid intake…
  • 2013 American Transplant Congress

    French Uncontrolled Donors after Circulatory Arrest (Udcd) Program for Kidney Transplantation: Procurement Procedure Efficiency and 3-Month Survival Results

    C. Antoine, E. Savoye, L. Jacob, G. Cheisson, B. Riou, L. Badet, M. Videcoq, G. Strecker, M. Thuong, National Steering Committee Non Heart Beating Donors Group

    Biomedecine Agency, La Plaine Saint Denis, France; Department of Anesthesia and Critical Care, Saint Louis Hospital, Paris, France; Department of Anesthesia and Critical Care, Bicetre Hospital, Kremlin Bicetre, France; Emergency Department, La Pitié Salpêtrière Hospital, Pitié, France; Department of Transplantation, Edouard Herriot Hospital Group, Lyon, France; Department of Anesthesia and Critical Care, Hôtel-Dieu Hospital, Nantes, France; Department of Anesthesia and Critical Care, Huriez Hospital, Lille, France

    The national protocol for the uDCD program restricts the no flow period to <30 min and the total warm ischemia time (WIT) to <150 min.…
  • 2013 American Transplant Congress

    Network Meta-Analysis of Immunosuppressant Regimens in Renal Preservation Following Liver Transplant, A

    F. Bianic, A. Davie, R. Campbell, J. Ricci, C. Escrig, S. Gokhale, J. Lake

    OptumInsight, Nanterre, France; OptumInsight, Uxbridge, United Kingdom; Wellmera AG, Basel, Switzerland; Novartis Pharma AG, Basel, Switzerland; Novartis Healthcare Pvt. Ltd., Hyderabad, India; University of Minnesota, MN

    Background: Long-term exposure to Calcineurin-Inhibitors (CNIs) has been associated with impaired renal function.Objective: To obtain parameter estimates of the relative renal safety of commonly used…
  • 2013 American Transplant Congress

    Interim Analysis of a Double-Blinded Placebo Controlled Trial of IVIG v. IVIG + Rituximab for Desensitization of Highly-HLA Sensitized (PRA >80%) (HS) Deceased Donor (DD) Candidates

    A. Vo, J. Choi, M. Lukovsky, M. Toyoda, S. Ge, J. Kahwaji, A. Peng, R. Villicana, R. Najjar, S. Jordan

    Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA; Transplant Immunology Laboratory, Cedars-Sinai Medical Center

    INTRODUCTION: Desensitization protocols (DES) for HS patients are primarily aimed at living-donor recipients. The efficacy of various DES is not established, especially for DD recipients.…
  • « Previous Page
  • 1
  • …
  • 90
  • 91
  • 92
  • 93
  • 94
  • …
  • 178
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences